We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Understand Enhertu dosage, administration, side effects, and what cancer patients in India need to know about this targeted therapy for breast, lung, and stomach cancers.
Facing cancer is a monumental challenge, and navigating treatment options can feel overwhelming. For patients in India dealing with specific types of breast, lung, or stomach cancer, a targeted therapy called Enhertu might be part of their treatment plan. This medication works differently from traditional chemotherapy, aiming specifically at cancer cells with certain genetic markers. But how is it administered? What does the dosage look like? And what should you expect?
Enhertu, also known by its generic name trastuzumab deruxtecan, is a powerful targeted therapy. It’s designed for cancers that are HER2-positive or HER2-low. HER2 is a protein that can help cancer cells grow. By targeting this protein, Enhertu aims to stop or slow down cancer growth.
In India, Enhertu is approved for specific indications, including:
It's crucial to understand that Enhertu is a prescription medication. Your oncologist, a cancer specialist, will determine if it’s the right fit for you based on the specific type and stage of your cancer, and importantly, the HER2 status of your tumour cells. This is usually determined through biopsy testing.
Enhertu is not a pill you take at home. It’s given as an intravenous (IV) infusion. This means a healthcare professional will administer it directly into your bloodstream through a vein, typically in a hospital or a specialized cancer treatment centre. This ensures precise delivery and allows for close monitoring during the infusion process.
The first Enhertu infusion is usually longer. It can take anywhere from 90 minutes to a couple of hours. This extended time allows your medical team to carefully watch for any immediate reactions to the medication. They are looking for things like fever, chills, or allergic responses.
If your first infusion goes smoothly and without significant side effects, subsequent infusions are generally quicker. They often take about 30 minutes. This efficiency is a relief for many patients undergoing lengthy treatments.
Perhaps one of the most frequently asked questions is about dosage. How much Enhertu do you receive? The simple answer is: it varies. Enhertu dosage is not one-size-fits-all. It is meticulously calculated based on two key factors:
While your doctor will provide your exact dosage, here are some general guidelines to give you an idea:
Important Note: These are illustrative examples. Your medical team will determine the precise dosage schedule tailored to your individual needs and treatment phase.
You might notice a pattern of decreasing doses (e.g., 5.4 mg/kg to 4.4 mg/kg to 3.2 mg/kg). This is known as step-down dosing. It’s a strategy used to manage potential side effects while still effectively treating the cancer. Once a dose is reduced, it’s generally not increased again.
Cancer treatment is dynamic. Your doctor may need to adjust or even temporarily pause your Enhertu infusions for several reasons:
Enhertu is typically administered once every 21 days. This 3-week period is called a treatment cycle. The duration of Enhertu treatment is often long-term. If both you and your doctor agree that Enhertu is working well and is safe for you, you might continue receiving it for an extended period.
Like all powerful medications, Enhertu can have side effects. It’s vital to be aware of them and report any concerns to your doctor promptly.
Serious Risks Highlighted by the FDA (and relevant globally):
Other common side effects might include fatigue, nausea, vomiting, hair loss, diarrhoea, and mouth sores. Your healthcare team will provide strategies to manage these.
It’s essential to maintain open communication with your oncology team. You should contact your doctor immediately if you experience:
Don't hesitate to ask questions. Your doctors and nurses are there to support you through every step of your treatment journey.
The maximum dose isn't a fixed number for everyone. It depends on your body weight and the specific condition being treated. For example, the maximum dose for breast or lung cancer might be 5.4 mg/kg, while for stomach cancer, it could be 6.4 mg/kg. Your doctor calculates this precisely for you.
Generally, having liver problems doesn't directly change your Enhertu dosage. However, your doctor will monitor you closely to ensure the medication isn't causing harm to your liver. If you have concerns about existing liver conditions, discuss them with your oncologist.
Yes, Enhertu is often used as a long-term treatment. If it proves to be safe and effective for you, your doctor may recommend continuing it for an extended period to manage your cancer.
If you miss an appointment, contact your doctor's office or the infusion center as soon as possible to reschedule. They will advise you on the best course of action.
Disclaimer: This information is for educational purposes and should not replace professional medical advice. Always consult with your qualified healthcare provider for any health concerns or before making any decisions related to your treatment.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026